Fresenius medical care successfully executes strategic plan and narrows guidance range due to strong operational performance in the first half of 2023

Organic growth accelerated in the second quarter in care enablement and care delivery including sequentially stable treatment volumes in the u.s. execution on turnaround plan translates into visible productivity improvements in care delivery achieving a q2 margin at the lower end of the 2025 target margin band savings resulting from fme25 transformation program fully on track successful execution on portfolio optimization strategy legal form conversion to a german stock corporation approved by shareholders fy 2023 operating income guidance range narrowed waltham, mass. , aug. 2, 2023 /prnewswire/ -- helen giza, chief executive officer of fresenius medical care, said: "the second quarter makes evident that the execution against our strategic plan is fully on track.
FMS Ratings Summary
FMS Quant Ranking